USD 31.54
(-1.73%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 596.24 Million USD | 2.05% |
2022 | 584.27 Million USD | 1.57% |
2021 | 575.21 Million USD | 29.49% |
2020 | 444.19 Million USD | 171.57% |
2019 | 163.56 Million USD | 9.58% |
2018 | 149.26 Million USD | 53.34% |
2017 | 97.34 Million USD | 1.15% |
2016 | 96.23 Million USD | 316.64% |
2015 | 23.09 Million USD | 7095.33% |
2014 | 321 Thousand USD | -7.23% |
2013 | 346 Thousand USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 595.26 Million USD | -0.16% |
2024 Q2 | 675.2 Million USD | 13.43% |
2024 Q3 | 654.48 Million USD | 0.06% |
2023 Q4 | 596.24 Million USD | 1.05% |
2023 Q3 | 590.04 Million USD | 0.44% |
2023 Q2 | 587.47 Million USD | 0.2% |
2023 Q1 | 586.29 Million USD | 0.35% |
2023 FY | 596.24 Million USD | 2.05% |
2022 Q2 | 577.22 Million USD | -0.11% |
2022 FY | 584.27 Million USD | 1.57% |
2022 Q3 | 579.5 Million USD | 0.4% |
2022 Q4 | 584.27 Million USD | 0.82% |
2022 Q1 | 577.83 Million USD | 0.46% |
2021 Q2 | 572.5 Million USD | 0.04% |
2021 FY | 575.21 Million USD | 29.49% |
2021 Q3 | 572.86 Million USD | 0.06% |
2021 Q4 | 575.21 Million USD | 0.41% |
2021 Q1 | 572.29 Million USD | 28.84% |
2020 Q2 | 163.17 Million USD | 0.27% |
2020 FY | 444.19 Million USD | 171.57% |
2020 Q4 | 444.19 Million USD | 3296.01% |
2020 Q3 | 13.08 Million USD | -91.98% |
2020 Q1 | 162.73 Million USD | -0.5% |
2019 Q4 | 163.56 Million USD | 1.75% |
2019 FY | 163.56 Million USD | 9.58% |
2019 Q3 | 160.75 Million USD | -0.11% |
2019 Q2 | 160.92 Million USD | 0.38% |
2019 Q1 | 160.32 Million USD | 7.4% |
2018 Q4 | 149.26 Million USD | 0.02% |
2018 FY | 149.26 Million USD | 53.34% |
2018 Q1 | 149.16 Million USD | 53.23% |
2018 Q2 | 149.19 Million USD | 0.02% |
2018 Q3 | 149.23 Million USD | 0.02% |
2017 Q4 | 97.34 Million USD | 0.3% |
2017 FY | 97.34 Million USD | 1.15% |
2017 Q1 | 96.49 Million USD | 0.27% |
2017 Q2 | 96.76 Million USD | 0.28% |
2017 Q3 | 97.04 Million USD | 0.29% |
2016 FY | 96.23 Million USD | 316.64% |
2016 Q4 | 96.23 Million USD | 0.27% |
2016 Q3 | 95.97 Million USD | 312.03% |
2016 Q2 | 23.29 Million USD | 0.43% |
2016 Q1 | 23.19 Million USD | 0.42% |
2015 Q2 | 24.53 Million USD | 0.07% |
2015 FY | 23.09 Million USD | 7095.33% |
2015 Q1 | 24.52 Million USD | 7538.94% |
2015 Q4 | 23.09 Million USD | -5.93% |
2015 Q3 | 24.55 Million USD | 0.06% |
2014 Q1 | - USD | 0.0% |
2014 FY | 321 Thousand USD | -7.23% |
2014 Q4 | 321 Thousand USD | 0.0% |
2013 FY | 346 Thousand USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | -595.683% |
AngioDynamics, Inc. | 5.91 Million USD | -9981.874% |
AtriCure, Inc. | 74.49 Million USD | -700.389% |
Avinger, Inc. | 15.39 Million USD | -3772.959% |
Azenta, Inc. | 60.43 Million USD | -886.568% |
BioLife Solutions, Inc. | 42.69 Million USD | -1296.646% |
The Cooper Companies, Inc. | 2.56 Billion USD | 76.793% |
Daxor Corporation | 755.65 Thousand USD | -78803.58% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | -8218.108% |
Femasys Inc. | 6.7 Million USD | -8797.963% |
GlucoTrack, Inc. | 196 Thousand USD | -304105.102% |
Harvard Bioscience, Inc. | 42.77 Million USD | -1293.968% |
Hologic, Inc. | 2.53 Billion USD | 76.476% |
ICU Medical, Inc. | 1.7 Billion USD | 65.024% |
Intuitive Surgical, Inc. | 89.8 Million USD | -563.967% |
KORU Medical Systems, Inc. | 4.44 Million USD | -13313.406% |
LeMaitre Vascular, Inc. | 19.09 Million USD | -3022.503% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 970 Million USD | 38.532% |
Microbot Medical Inc. | 231 Thousand USD | -258013.42% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -8033.012% |
Merit Medical Systems, Inc. | 891.35 Million USD | 33.109% |
Nephros, Inc. | 1.83 Million USD | -32375.054% |
NEXGEL, Inc. | 2.79 Million USD | -21209.578% |
NEXGEL, Inc. | 2.79 Million USD | -21209.578% |
Singular Genomics Systems, Inc. | 75.28 Million USD | -691.948% |
OraSure Technologies, Inc. | 13.5 Million USD | -4315.299% |
Pro-Dex, Inc. | 13.54 Million USD | -4301.284% |
Pulse Biosciences, Inc. | 9.14 Million USD | -6420.582% |
Predictive Oncology Inc. | 2.85 Million USD | -20770.872% |
Precision Optics Corporation, Inc. | 3.43 Million USD | -17260.57% |
QuidelOrtho Corporation | 2.61 Billion USD | 77.191% |
Repligen Corporation | 711.8 Million USD | 16.235% |
Sanara MedTech Inc. | 11.79 Million USD | -4956.279% |
STAAR Surgical Company | 35.83 Million USD | -1563.9% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -174239.766% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | 74.065% |
Jin Medical International Ltd. | 4.11 Million USD | -14396.523% |